Invention Grant
- Patent Title: Methods of producing sesquiterpene compounds
-
Application No.: US16308890Application Date: 2017-07-19
-
Publication No.: US11293040B2Publication Date: 2022-04-05
- Inventor: Michel Schalk , Letizia Rocci
- Applicant: Firmenich SA
- Applicant Address: CH Geneva
- Assignee: Firmenich SA
- Current Assignee: Firmenich SA
- Current Assignee Address: CH Geneva
- Agency: Armstrong Teasdale LLP
- Priority: GB1612609 20160720,EP17159264 20170303
- International Application: PCT/EP2017/068268 WO 20170719
- International Announcement: WO2018/015453 WO 20180125
- Main IPC: C12P7/62
- IPC: C12P7/62 ; C12P5/00 ; C12P7/22 ; C12P7/26 ; C12N9/02 ; C12N9/88 ; C12N15/70

Abstract:
Provided is a method of producing one or more sesquiterpene compounds comprising: contacting an acyclic FPP precursor with a polypeptide having terpene synthase activity, wherein the polypeptide comprises an amino acid sequence that has at least 55% sequence identity to SEQ ID NO: 1, to produce one or more terpenes selected from the group consisting of isovalencene, spirovetiva-1(10),7(11)-diene and valencene or derivatives thereof, or mixture of sesquiterpenes comprising one or more of isovalencene, spirovetiva-1(10),7(11)-diene and/or valencene; and optionally isolating the one or more terpenes or the mixture. Also described is a nucleic acid derived from Vetiveria zizanoides encoding a polypeptide having sesquiterpene synthase activity, a polypeptide that can be used to produce one or more sesquiterpenes or a mixture of sesquiterpenes comprising one or more of isovalencene, spirovetiva-1(10),7(11)-diene and/or valencene, and a non-human organism or cell comprising the nucleic acid or comprising an expression vector comprising the nucleic acid.
Public/Granted literature
- US20200308612A1 VETIVER Public/Granted day:2020-10-01
Information query